Cancer Treatment Reviews
Volume 30, Issue 7 , Pages 651-653, November 2004

Gefitinib does not improve survival when combined with gemcitabine and cisplatin in people with advanced non-small-cell lung cancer:☆☆☆☆☆☆

Abstracted from: Giaccone G, Herbst RS, Manegold C et al. Gefitinib in combination with gemcitabine and cisplatin in advanced non-small-cell lung cancer: a phase III trial-INTACT 1. J Clin Oncol 2004;22:777–784.

published online 27 October 2004.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

☆ Sources of funding: This study was funded by Astra Zeneca, Wilmington, Delaware, USA.

☆☆ For correspondence: Giuseppe Giaccone, Vrije Universiteit Medical Center, Department of Oncology, De Boelelaan 1117, 1081 Amsterdam, The Netherlands. E-mail: g.giaccone@vumc.nl.

☆☆☆ Abstract provided by Bazian Ltd., London.

PII: S0305-7372(04)00143-4

doi:10.1016/j.ctrv.2004.08.001

Cancer Treatment Reviews
Volume 30, Issue 7 , Pages 651-653, November 2004

Article Tools